Pulse Pressure and Systolic Blood Pressure are Powerful Independent Predictors of Cardiovascular Disease in Diabetic Adults: Results of an 8.4 years Follow-up of Tehran Lipid and Glucose Study (TLGS)

Abstract

Aim: To determine the role of different blood pressure (BP) components as predictors of cardiovascular disease (CVD) in diabetic patients.

Methods: We followed 828 diabetic patients, aged ≥30 years, without baseline CVD and not taking antihypertensive drugs. The hazard ratios (HRs) for CVD were calculated for a 1 standard deviation (SD) change in each BP measure using Cox proportional regression analysis.

Results: During median 8.4 year- follow up, 134 CVD events occurred. Systolic BP (SBP), pulse pressure (PP) and mean arterial pressure (MAP) were independent predictors of CVD with multivariate adjusted hazard ratios (HRs) of 1.35, 1.36 and1.23 respectively (all p<0.05) and similar discriminatory power (C statistics≈75% ). The multivariate models containing MAP plus one other BP component highlighted the significant improvement in the goodness of fit to predict incident CVD (likelihood ratio test=0.01); however this was not so for SBP and PP. In the elderly subjects, only PP and SBP were significantly associated with CVD.

Conclusion: The SBP and PP are significant independent predictors of CVD in all diabetic populations (including younger and elder groups) and other BP components did not add to these measures in risk prediction.

Key words

blood pressure - cardiovascular disease - diabetes

References

• 1 Agresti A. Building and Applying Logistic Regression Models: AN introduction to categorical Data Analysis.. 2th ed. John Wiley &Sons, Inc, Hoboken, New Jersey; 2007
• 2 Airaksinen KE, Salmela PI, Linnaluoto MK. et al . Diminished arterial elasticity in diabetes: association with fluorescent advanced glycosylation end products in collagen.  Cardiovasc Res. 1993;  27 942-945
• 3 Asia Pacific Cohort Studies Collaboration . Cholesterol, diabetes and major cardiovascular diseases in the Asia-Pacific region.  Diabetologia. 2007;  50 2289-2297
• 4 Assmann G, Cullen P, Evers T. et al . Importance of arterial pulse pressure as a predictor of coronary heart disease risk in PROCAM.  Eur Heart J. 2005;  26 2120-2126
• 5 Azizi F, Ghanbarian A, Momenan AA. et al . Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II.  Trials. 2009;  10 5
• 6 Azizi F, Rahmani M, Emami H. et al . Tehran Lipid and Glucose Study: rationale and design.  CVD Prevention. 2000;  3 242-247
• 7 Cockcroft JR, Wilkinson IB, Evans M. et al . Pulse pressure predicts cardiovascular risk in patients with type 2 diabetes mellitus.  Am J Hypertens. 2005;  18 1463-1467 discussion 1468–1469
• 8 Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction.  Circulation. 2007;  115 928-935
• 9 Domanski M, Mitchell G, Pfeffer M. et al . Pulse pressure and cardiovascular disease-related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT).  JAMA. 2002;  287 2677-2683
• 10 Domanski M, Norman J, Wolz M. et al . Cardiovascular risk assessment using pulse pressure in the first national health and nutrition examination survey (NHANES I).  Hypertension. 2001;  38 793-797
• 11 Franklin SS, Khan SA, Wong ND. et al . Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study.  Circulation. 1999;  100 354-360
• 12 Franklin SS, Larson MG, Khan SA. et al . Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study.  Circulation. 2001;  103 1245-1249
• 13 Genuth S, Alberti KG, Bennett P. et al . Follow-up report on the diagnosis of diabetes mellitus.  Diabetes Care. 2003;  26 3160-3167
• 14 Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971–1993.  Diabetes Care. 1998;  21 1138-1145
• 15 Hadaegh F, Bozorgmanesh MR, Ghasemi A. et al . High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study.  BMC Public Health. 2008;  8 176
• 16 Hadaegh F, Harati H, Ghanbarian A. et al . Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study.  Eur J Cardiovasc Prev Rehabil. 2006;  13 571-577
• 17 Hadaegh F, Harati H, Ghanbarian A. et al . Prevalence of coronary heart disease among Tehran adults: Tehran Lipid and Glucose Study.  East Mediterr Health J. 2009a;  15 157-166
• 18 Hadaegh F, Khalili D, Fahimfar N. et al . Glucose intolerance and risk of cardiovascular disease in Iranian men and women: results of the 7.6-year follow-up of the Tehran Lipid and Glucose Study (TLGS).  J Endocrinol Invest. 2009b;  32 724-730
• 19 Hadaegh F, Khalili D, Ghasemi A. et al . Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men.  Nutr Metab Cardiovasc Dis. 2009c;  19 401-408
• 20 Haider DG, Mittermayer F, Friedl A. et al . Postprandial blood glucose level in maintenance hemodialysis patients predicts post-transplant-diabetes-mellitus.  Exp Clin Endocrinol Diabetes. 2010;  118 200-204
• 21 Harati H, Hadaegh F, Saadat N. et al . Population-based incidence of Type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran.  BMC Public Health. 2009;  9 186
• 22 Kannel WB, Dawber TR, McGee DL. Perspectives on systolic hypertension. The Framingham study.  Circulation. 1980;  61 1179-1182
• 23 Luepker RV, Apple FS, Christenson RH. et al . Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute.  Circulation. 2003;  108 2543-2549
• 24 Mosley WJ, Greenland P, Garside DB. et al . Predictive utility of pulse pressure and other blood pressure measures for cardiovascular outcomes.  Hypertension. 2007;  49 1256-1264
• 25 Nawroth PP, Rudofsky G, Humpert P. Have we understood diabetes? New tasks for diagnosis and therapy.  Exp Clin Endocrinol Diabetes. 2010;  118 1-3
• 26 Nilsson PM, Cederholm J, Eeg-Olofsson K. et al . Pulse pressure strongly predicts cardiovascular disease risk in patients with type 2 diabetes from the Swedish National Diabetes Register (NDR).  Diabetes Metab. 2009;  35 439-446
• 27 Pencina MJ, D’Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation.  Statist Med. 2004;  23 2109-2123
• 28 Psaty BM, Furberg CD, Kuller LH. et al . Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: the cardiovascular health study.  Arch Intern Med. 2001;  161 1183-1192
• 29 Roger N. Parameters behind “nonparametric” statistic: Kendall's tau, Somers’D and median differences.  STATA J. 2002;  2 45-64
• 30 Safar ME. Pulse pressure, arterial stiffness, and cardiovascular risk.  Curr Opin Cardiol. 2000;  15 258-263
• 31 Sanjari M, Hedayati M, Azizi F. Prevalence of Type 2 Diabetes Mellitus in 3–19 Age Group in East of Tehran in 2001.  Irainian Juranal of Endocrinology & Metabolism. 2007;  9 119-126
• 32 Schram MT, Chaturvedi N, Fuller JH. et al . Pulse pressure is associated with age and cardiovascular disease in type 1 diabetes: the Eurodiab Prospective Complications Study.  J Hypertens. 2003;  21 2035-2044
• 33 Schram MT, Henry RM, van Dijk RA. et al . Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study.  Hypertension. 2004;  43 176-181
• 34 Schram MT, Kostense PJ, Van Dijk RA. et al . Diabetes, pulse pressure and cardiovascular mortality: the Hoorn Study.  J Hypertens. 2002;  20 1743-1751
• 35 Schram MT, Schalkwijk CG, Bootsma AH. et al . Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study.  Hypertension. 2005;  46 232-237
• 36 Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update.  Hypertension. 2001;  37 1053-1059
• 37 Stehouwer CD, Henry RM, Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease.  Diabetologia. 2008;  51 527-539
• 38 Wilson PW, D’Agostino RB, Levy D. et al . Prediction of coronary heart disease using risk factor categories.  Circulation. 1998;  97 1837-1847
• 39 Wittek A, Sokalski B, Grzeszczak W. et al . Prevalence of diabetes and cardiovascular risk factors of industrial area in southern Poland.  Exp Clin Endocrinol Diabetes. 2009;  117 350-353
• 40 Zabetian A, Hadaegh F, Azizi F. Relationship between metabolic syndrome and its components with coronary heart disease in Iranian men and women.  Exp Clin Endocrinol Diabetes. 2008;  116 525-531

Correspondence